Zhejiang AngLiKang Pharmaceutical CO.,LTD. (SHE:002940)
China flag China · Delayed Price · Currency is CNY
27.81
+0.31 (1.13%)
Jun 12, 2026, 3:04 PM CST

SHE:002940 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
607.14687.41697.38859.75735.47688.91
Trading Asset Securities
283.96102.2636.041069.359.6
Cash & Short-Term Investments
891.09789.67733.42869.75804.76748.51
Cash Growth
15.17%7.67%-15.68%8.08%7.52%-12.36%
Accounts Receivable
228.63218.89234.32244.86295.51301.32
Other Receivables
3.468.249.8521.456.7717.27
Receivables
232.09227.13244.18266.31302.28318.59
Inventory
512.31447.47503.79393.44293.23299.6
Other Current Assets
30.8521.5817.4832.4351.699.25
Total Current Assets
1,6661,4861,4991,5621,4521,376
Property, Plant & Equipment
616.44617.28603.86615.8445.7474.63
Long-Term Investments
293.08304.84304.7301.41302.15147.34
Goodwill
312.94312.94312.94312.9421.9821.98
Other Intangible Assets
121.16123.57133.55139.1438.7840.05
Long-Term Deferred Tax Assets
39.7239.1250.0632.7722.4420.65
Long-Term Deferred Charges
52.4152.6449.4835.060.981.6
Other Long-Term Assets
13.2914.5721.0720.95312.091.36
Total Assets
3,1152,9512,9753,0202,5962,084
Accounts Payable
458.82434.09485.45402.49320.45335.97
Accrued Expenses
25.0294.34120.24130.41220.56218.67
Short-Term Debt
256.14142.42163.37134.9171.941.76
Current Portion of Long-Term Debt
25.9869.7420.2130.425.02-
Current Portion of Leases
---0.26--
Current Income Taxes Payable
4.233.85.579.34-2.88
Current Unearned Revenue
22.823.9232.3118.7241.6731.9
Other Current Liabilities
110.9544.7316.395.458.954.1
Total Current Liabilities
903.94813.03843.54731.97788.59595.29
Long-Term Debt
289.5242.26303.5423.95150-
Long-Term Unearned Revenue
19.4417.6416.7817.859.7313.3
Long-Term Deferred Tax Liabilities
10.4610.6712.2913.951.60.06
Total Liabilities
1,2231,0841,1761,188949.93608.64
Common Stock
201.73201.73201.73201.73139.1295.95
Additional Paid-In Capital
708.28708.28684.01723.84782.91824.87
Retained Earnings
811.88794.22712.9674.51577.87478.74
Treasury Stock
-84.1-84.1-74.5-20.12--63.34
Comprehensive Income & Other
8.287.156.46.252.752.64
Total Common Equity
1,6461,6271,5311,5861,5031,339
Minority Interest
245.99239.94267.87246.07143.5136.08
Shareholders' Equity
1,8921,8671,7981,8321,6461,475
Total Liabilities & Equity
3,1152,9512,9753,0202,5962,084
Total Debt
571.62454.42487.08589.52346.961.76
Net Cash (Debt)
319.48335.25246.34280.23457.8746.75
Net Cash Growth
29.90%36.09%-12.10%-38.79%-38.69%-11.34%
Net Cash Per Share
1.63-1.231.402.303.74
Filing Date Shares Outstanding
196.11-196.89199.71197.4197.4
Total Common Shares Outstanding
196.11-196.89199.71197.4197.4
Working Capital
762.4672.82655.33829.96663.37780.67
Book Value Per Share
8.39-7.777.947.616.78
Tangible Book Value
1,2121,1911,0841,1341,4421,277
Tangible Book Value Per Share
6.18-5.515.687.306.47
Buildings
-453.09447.5435.42314.48319.46
Machinery
-677.06640.01628.95467.67439.73
Construction In Progress
-79.7549.622.5225.3329.94